Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.12.2015 | short review

Thermoablation: a new treatment option to replace surgical intervention?

verfasst von: Dr. Herbert Schuster, MD, Dr. Helmut Kopf

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Local tumor ablation either by high or low temperatures is an ever increasing local therapeutic procedure in the interdisciplinary armamentarium of anticancer therapy. As cryoablation (local cancer tissue destruction by low temperature) is technically demanding, rather expansive and thus has gained low acceptance and low distribution in interventional oncologic radiology, this paper will focus on the state-of-the-art of local tumor cell destruction by high temperatures and electroporation: radiofrequency ablation (RFA), microwave ablation (MWA), and irreversible electroporation (IRE).
Vorheriger Artikel Malignant pleural effusion: pathogenesis, diagnosis, and management
Nächster Artikel Giant Merkel cell carcinoma of the face, immediate results after radiation therapy: a case report and review of the literature
Literatur
1.
2.
Bruix J, Sherman M, Llovet JM, et al.; EASL panel of experts on HCC. Clinical management of study of the liver. J Hepatol. 2001;35:421–30.
3.
4.
Lencioni R, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology. 2003;228(1):235–40PubMedCrossRef
5.
Llovet JM, Vilana R, Bru C, et al.; Barcelona Clinic Liver Cancer (BCLC) Group. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology. 2001;33:1124–9.
6.
Ruers T, et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol. 2012;23(10):2619–26.PubMedPubMedCentralCrossRef
7.
Ruers T, et al. Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): long-term survival results of a randomized phase II study of the EORTC-NCRI CCSG- ALM Intergroup 40004 (CLOCC). J Clin Oncol. 2015; 33. (suppl; abstr 3501; oral presentation)
8.
9.
Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243(3):321–8.PubMedPubMedCentralCrossRef
10.
Lu MD, Kuang M, Liang LJ, Xie XY, Peng BG, et al. Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi. 2006;86(12):801–5.PubMed
11.
Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242(2):158–71.PubMedPubMedCentralCrossRef
12.
Silen W. Hepatic resection for metastases from colorectal carcinoma is of dubious value. Arch Surg. 1989;124(9):1021–2.PubMedCrossRef
13.
Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection. The “Test-of-Time” approach. Cancer. 2003;97(12):3027–35.PubMedCrossRef
14.
15.
Abi-Jaoudeh N, Kruecker J, Kadoury S, et al. Multimodality image fusion-guided procedures: technique, accuracy and applications. Cardiovasc Intervent Radiol. 2012;35:986–98.PubMedPubMedCentralCrossRef
16.
Wood BJ, Kruecker J, Abi-Jaoudeh N, et al. Navigation systems for ablation. J Vasc Interv Radiol. 2010;21:257–63.CrossRef
17.
Wallach D, Toporek G, Weber S, Bale R, Widmann G. Comparison of freehand-navigated and aiming device-navigated targeting of liver lesions. Int J Med Robot. 2014;10(1):35–43.PubMedCrossRef
18.
Peng ZW, Zhang YJ, Chen MS, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol. 2013;31:426–32.PubMedCrossRef
19.
Strickland AD, Clegg PJ, Cronin NJ, et al. Experimental study of large-volume microwave ablation in the liver. Br J Surg. 2002;89(8):1003–7.PubMedCrossRef
20.
Yang D, Converse MC, Mahvi DM, Webster JG. Measurement and analysis of tissue temperature during microwave liver ablation. IEEE Trans Biomed Eng. 2007;54(1):150–5.PubMedCrossRef
21.
Wang Y, Sun Y, Feng L, Gao Y, Ni X, Liang P. Internally cooled antenna for microwave ablation: results in ex vivo and in vivo porcine livers. Eur J Radiol. 2008;67(2):357–61.PubMedCrossRef
22.
Van Sonnenberg E, McMullen W, Solbiati L. Tumor ablation. Principles and practice. New York: Springer; 2005.CrossRef
23.
Davalos R, Mir LM, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33(2):223–31.PubMedCrossRef
24.
Maor E, Ivorra A, Leor J, Rubinsky B. The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat. 2007;6(307):307–12.PubMedCrossRef
25.
Narayanan G, Bhatia S, Echenique A, Suthar R, Barbery K, Yrizarry J. Vessel patency post irreversible electroporation. Cardiovasc Intervent Radiol. 2014;37(6):1523–9.PubMedCrossRef
26.
27.
Lencioni R, Crocetti L, Cioni D et al (2004) Percutaneous radiofrequency ablation of hepatic colorectal metastases. Technique, indications, results, and new promises. Invest Radiol 39:689–697
28.
Gillams AR, Lees WR (2004) Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 14:2261–2267
29.
Machi J, Oishi AJ, Sumida K et al (2006) Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line management. Cancer J 12:318–326
30.
Sorensen SM, Mortensen FV, Nielsen DT (2007) Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol 48:253–258
31.
Veltri A, Sacchetto P, Tosetti I, Pagano E, Fava C, Gandini G (2008) Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technique effectiveness and survival. Cardiovasc Intervent Radiol 31:948–956
Metadaten
Titel
Thermoablation: a new treatment option to replace surgical intervention?
verfasst von
Dr. Herbert Schuster, MD
Dr. Helmut Kopf
Publikationsdatum
01.12.2015
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 4/2015
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-015-0232-6

Weitere Artikel der Ausgabe 4/2015

ASCO 2015: Highlights in breast cancer

  • review

American Society of Clinical Oncology annual meeting 2015

  • editorial

Gastric and esophageal cancer: Post ASCO 2015

  • short review

Malignant pleural effusion: pathogenesis, diagnosis, and management

  • review

Obituary for Dr. Ferdinand Ploner

  • Obituary

Soft tissue sarcomas & GIST Insights into subtype-specific therapy concepts: Highlights from ASCO meeting 2015

  • short review